Latham & Watkins represented Arcutis in the transaction. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing novel innovations in immuno-dermatology, has announced that...
Arcutis Biotherapeutics’ $225 Million Non-Dilutive Debt Financing
Silver Spike Acquisition Corp. II’s $446 Million Combination With Eleusis
Davis Polk advised Silver Spike Acquisition Corp. II on the deal, while Latham & Watkins represented Eleusis. Silver Spike Acquisition Corp. II announced its approximately $446...
Coherus BioSciences’ $300 Million Credit Financing with Pharmakon Advisors
Latham & Watkins represented Coherus in the transaction. Coherus BioSciences, Inc. (Coherus or the Company) (Nasdaq: CHRS) has entered into a loan agreement with investment funds managed...
Encap Flatrock Midstream’s $400 Million Capital Commitment in Clearfork
Vinson & Elkins advised Clearfork Midstream on the deal, while Latham & Watkins represented Encap Flatrock Midstream. Clearfork Midstream announced its $400 million capital commitment from Encap Flatrock Midstream....
Fertitta Entertainment’s $2.25 Billion Notes Private Offering
Latham & Watkins represented Fertitta Entertainment in the offering. Fertitta Entertainment, LLC (f/k/a Golden Nugget, LLC), a multinational, diversified gaming, restaurant, hospitality, and entertainment company, has announced...
TPG Real Estate’s Tender Offer and Acquisition of a Majority Stake in Studio Babelsberg
Kirkland & Ellis has advised TPG Real Estate Partners on the deal. TPG Real Estate Partners (TREP) announced the successful tender offer for shares in Studio...
Permira’s Investment in BPL and Kedrion
Goodwin Procter advised Bio Products Laboratory and Tiancheng International Investment Limited on the deal. The shareholders of Kedrion was advised by Carnelutti and Pedersoli Studio Legale,...
Desert Peak Minerals’ $1.9 Billion Merger With Falcon Minerals Corporation
Latham & Watkins advised Falcon, and White & Case advised the Transaction Committee. Vinson & Elkins represented Desert Peak and Kimmeridge. Kirkland & Ellis counseled Blackstone...
UCB’s Acquisition of Zogenix
Covington represented UCB, while Latham & Watkins represented Zogenix on the deal. Fried Frank acted as counsel to BofA Securities and SVB Leerink as financial advisors to...
Vaxcyte’s $100 Million Shares Offering
Latham & Watkins represented the underwriters in the transaction. Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of...
Alpac Capital’s Acquisition of Euronews
Latham & Watkins has advised Media Globe Networks on the deal. CCSL Advogados assisted Alpac Capital. Media Globe Networks (MGN), a company owned by the Sawiris...
TravelPerk’s $115 Million Series D-1 Financing
Latham & Watkins represented TravelPerk in the transaction. TravelPerk, one of the largest and fastest growing global travel management platforms, has announced it raised US$115 million bringing...